Choonara Y.E.

Publications

530

Citations

15.0K

h-index

60

Publishing journals

199

Years of publications

20+

Active since

2007

References

35.8K

Institutions

9

1. A Review of Chemical Approaches Inherent to Endodontic Disinfection Protocols: Part 2
   South African Dental Journal, Volume 80, Issue 08, Pages 422-431, Year 2026
2. Design of a Thermoresponsive Nose-to-Brain Neuromaterial for the Release of Naturally Derived Extracellular Vesicles Delivering Teriflunomide for Multiple Sclerosis.
   AAPS PharmSciTech, Volume 27, Issue 3, Year 2026
3. A Comprehensive Review of the Revolutionary Potential of Blockchain in Safe, Secure, and Sustainable Pharmaceutical Operations.
   Pharmaceutical research, Year 2026
4. Recent advances in interstitial fluid dynamics for diagnostic, targeted drug delivery and precision medicine applications
   Drug Delivery and Translational Research, Year 2026
5. Call for Papers: Advances in Pharmaceutical Sciences in Africa.
   Molecular pharmaceutics, Volume 23, Issue 4, Pages 2217-2218, Year 2026
6. A Review of Nanoparticle‐Based Astrocyte Modulation in CNS Disorders: Evaluating the Underexplored Potential of Intranasal Delivery
   Nano Select, Volume 7, Issue 1, No. e70089, Year 2026
7. Breaking the Barrier of Brain Disease Therapeutics: Advocating Targeted Drug Delivery for Improved Neuro-Resident Interventions
   AAPS PharmSciTech, Volume 27, Issue 3, No. 128, Year 2026
8. Non-surgical Synergistic Interventions for the Treatment of Skin Cancer.
   Current pharmaceutical design, Volume 32, Issue 4, Pages 245-260, Year 2026
9. A pH-Responsive Poly Beta-Amino Ester Nanoparticulate Thermo-Responsive PEG-PCL-PEG Hydrogel Dispersed System for the Delivery of Interferon Alpha to the Ocular Surface
   Pharmaceutics, Volume 17, Issue 6, Pages 709-709, Year 2025
10. Achieving Optimal Health With Host‐Directed Therapies (HDTs) in Infectious Diseases—A New Horizon
    Advanced Therapeutics, Volume 8, Issue 4, No. 2400169, Year 2025
11. Extracellular nanovesicles as neurotherapeutics for central nervous system disorders
    Expert Opinion on Drug Delivery, Volume 22, Issue 1, Pages 69-84, Year 2025
12. Advancing Tuberculosis Chemotherapy: Targeted Nanomedicines for the Mycobacterium TB Granuloma.
    Small (Weinheim an der Bergstrasse, Germany), Volume 21, Issue 49, No. e06381, Page e06381, Year 2025
13. Modified-Release Pulmonary Delivery Systems for Labile Bioactives: Design, Development, and Applications
    Pharmaceutics, Volume 17, Issue 4, No. 470, Pages 470-470, Year 2025
14. Advances in targeted therapies and emerging strategies for blood cancer treatment
    RSC Pharmaceutics, Volume 2, Issue 5, Pages 950-961, Year 2025
15. Co-Formulation of Iron Oxide and PLGA Nanoparticles to Deliver Curcumin and IFNα for Synergistic Anticancer Activity in A375 Melanoma Skin Cancer Cells
    Pharmaceutics, Volume 17, Issue 7, Pages 860-860, Year 2025
16. Metallic and lipid nanoparticles against multidrug resistant Candida : advances and translational hurdles
    Expert Opinion on Drug Delivery, Volume 22, Issue 11, Pages 1727-1749, Year 2025
17. Isolation and characterization of medicinal plant-based extracellular vesicles as nano delivery systems for ascorbic acid
    Journal of Microencapsulation, Volume 42, Issue 2, Pages 120-131, Year 2025
18. Functionalized Polydopamine Nanoparticles: A Promising Drug Delivery Platform for the Treatment of Tuberculosis.
    Drug development research, Volume 86, Issue 4, No. e70109, Pages e70109-e70109, Year 2025
19. A Dual-Template Molecularly Imprinted Polymer to Inhibit Quorum Sensing Molecules: Theoretical Design, Optimized Synthesis, Physicochemical Characterization and Preliminary Microbiological Analysis
    International Journal of Molecular Sciences, Volume 26, Issue 16, Pages 8015-8015, Year 2025
20. The modification of conventional liposomes for targeted antimicrobial delivery to treat infectious diseases
    Discover Nano, Volume 20, Issue 1, No. 19, Year 2025

No publications in the index yet.